{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-116439","form_type":"8-K","ticker":"HIMS","cik":"0001773751","company_name":"Hims & Hers Health, Inc.","filed_at":"2025-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.662862+00:00","generated_at":"2026-05-22T01:58:22.811310+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Hims & Hers prices $870M 0.00% convertible notes due 2030 for global expansion and AI investment","bullets":["Initial $450M offering upsized to $870M; initial purchasers option for additional $130M.","Zero-coupon notes due 2030; initial conversion price ~$70.67/share (37.5% premium over $51.40 close).","Net proceeds est. $842.7M ($968.8M if full exercise); ~$41.6M for capped call transactions.","Proceeds for global expansion (organic + M&A), AI/data platform; no material acquisition agreements yet.","New CTO Mo Elshenawy leading tech team to develop AI tools and personalized treatments."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-116439","json":"https://secwatch.observer/filing/0001193125-25-116439.json","markdown":"https://secwatch.observer/filing/0001193125-25-116439.md","text":"https://secwatch.observer/filing/0001193125-25-116439.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1773751/000119312525116439/0001193125-25-116439-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1773751/000119312525116439/d905005d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T01:58:22.811310+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}